Status:
COMPLETED
Rhodiola Crenulata as an Adjunctive Therapy in COPD
Lead Sponsor:
Chung Shan Medical University
Conditions:
COPD
Eligibility:
All Genders
40-85 years
Phase:
PHASE2
Brief Summary
We hypothesize that add-on Rhodiola L extract capsule to the regimen of patients with moderate-to-severe COPD (1) may provide a potential of systemic effects of anti-inflammation and anti-oxidation fo...
Detailed Description
This is a single center, randomized, double-blind, placebo controlled clinical trial. Eligibility criteria: 1. moderate-to-severe COPD patients 2. aged 40-80 years, 3. abstaining from cigarette smok...
Eligibility Criteria
Inclusion
- moderate-to-severe COPD patients
- aged 40-80 years,
- abstaining from cigarette smoking or maintaining a stable dose of cigarette consumption,
- no acute exacerbation of COPD,
- clinically being stable for one month and longer,
- not undergoing exercise training program.
Exclusion
- uncontrolled diabetes mellitus by plasma fasting sugar \>200 mg/dl,
- uremia or CKD stage 5,
- chronic heart failureby NYFC III,
- cerebrovascular disease,
- uncontrolled anemia by Hb \< 10 mg/dl,
- active malignant diseases,
- other hospitalized acute illness,
- systemic prednisolone \> 10 mg per day.
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT02242461
Start Date
May 1 2012
End Date
July 1 2013
Last Update
September 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Critical Care Medicine and Division of Pulmonary Medicine
Dawan, Ming-Lung Chuang, Taiwan